Is HMTXF or DIVO a better dividend investment in 2026?

HMTXF currently yields 4072.49% with a 5% 5-year dividend growth rate. DIVO yields 6.49% with 5% growth. The better choice depends on your goal: HMTXF offers higher current income.

What is the dividend yield difference between HMTXF and DIVO?

HMTXF has a forward dividend yield of 4072.49% ($2.00/share annually). DIVO yields 6.49% ($2.91/share annually). The yield gap is 4066.00 percentage points.

Home › Compare › HMTXF vs DIVO

HMTXF vs DIVO: Dividend Comparison 2026

HMTXF yields 4072.49% · DIVO yields 6.49%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 HMTXF wins by $8532781061001.10M in total portfolio value

INVESTMENT

TIME HORIZON10 years

HMTXF

● Live price

4072.49%

Share price

$0.05

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$8532781061001.13M

Annual income

$8,139,610,200,782,360,000.00

Full HMTXF calculator →

DIVO

● Live price

6.49%

Share price

$44.85

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$981.68

Full DIVO calculator →

Portfolio growth — HMTXF vs DIVO

📍 HMTXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	HMTXF	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, HMTXF + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

HMTXF pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HMTXF

Annual income on $10K today (after 15% tax)

$346,161.68/yr

After 10yr DRIP, annual income (after tax)

$6,918,668,670,665,005,000.00/yr

DIVO

Annual income on $10K today (after 15% tax)

$552.00/yr

After 10yr DRIP, annual income (after tax)

$834.43/yr

At 15% tax rate, HMTXF beats the other by $6,918,668,670,665,004,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HMTXF + DIVO for your $10,000?

HMTXF: 50%DIVO: 50%

100% DIVO50/50100% HMTXF

Portfolio after 10yr

$4266390530500.58M

Annual income

$4,069,805,100,391,180,300.00/yr

Blended yield

95.39%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HMTXF buys

DIVO buys

No recent congressional trades found for HMTXF or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricHMTXFDIVO

Forward yield	4072.49% ✓	6.49%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$8532781061001.13M ✓	$30.7K
Annual income after 10y	$8,139,610,200,782,360,000.00 ✓	$981.68
Total dividends collected	$8505980562203.27M ✓	$8.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: HMTXF vs DIVO ($10,000, DRIP)

Year	HMTXF Portfolio	HMTXF Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$417,949	$407,249.03	$11,349	$649.42	+$406.6K → HMTXF
2	$16,354,620	$15,907,414.89	$12,833	$688.83	+$16.34M → HMTXF
3	$599,244,865	$581,745,420.76	$14,459	$727.90	+$599.23M → HMTXF
4	$20,562,279,794	$19,921,087,789.34	$16,238	$766.49	+$20562.26M → HMTXF
5	$660,847,691,261	$638,846,051,880.89	$18,179	$804.47	+$660847.67M → HMTXF
6	$19,895,674,352,505	$19,188,567,322,855.41	$20,293	$841.71	+$19895674.33M → HMTXF
7	$561,191,767,703,669	$539,903,396,146,489.40	$22,591	$878.14	+$561191767.68M → HMTXF
8	$14,833,096,999,026,612	$14,232,621,807,583,686.00	$25,087	$913.65	+$14833096999.00M → HMTXF
9	$367,449,402,073,618,800	$351,577,988,284,660,350.00	$27,791	$948.18	+$367449402073.59M → HMTXF
10	$8,532,781,061,001,133,000	$8,139,610,200,782,360,000.00	$30,718	$981.68	+$8532781061001.10M → HMTXF

HMTXF vs DIVO: Complete Analysis 2026

HMTXF — Stock

Hemostemix Inc., a biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions. The company develops cell therapy products from the patient's own blood, which is a non-invasive source of therapeutic cells. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of critical limb ischemia in Canada and the United States, as well as for the treatment of heart and peripheral arterial diseases. The company is also developing various types of cell products, such as synergetic cell populations and neural cell precursors. Hemostemix Inc. is headquartered in Calgary, Canada.

Full HMTXF Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this HMTXF vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HMTXF vs SCHD HMTXF vs JEPI HMTXF vs O HMTXF vs KO HMTXF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.